Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Head and/or Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02609386
What this trial is testing

IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity

Who this might be right for
Squamous Cell Carcinoma of the Oral Cavity
Brooklyn ImmunoTherapeutics, LLC 105
Early research (Phase 1)Study completedNCT00101972
What this trial is testing

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Who this might be right for
Cancer
MacroGenics 53
Testing effectiveness (Phase 2)Ended earlyNCT05363605
What this trial is testing

[225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorHead and Neck Squamous Cell CarcinomaBladder Carcinoma+11 more
Fusion Pharmaceuticals Inc. 6
Testing effectiveness (Phase 2)Study completedNCT00697905
What this trial is testing

Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Ministry of Health, Malaysia 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07818486
What this trial is testing

BL-M08D1 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma and Other Solid Tumors

Who this might be right for
Nasopharyngeal Carcinoma (NPC)Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06251973
What this trial is testing

AgenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer

Who this might be right for
Metastatic Esophageal CarcinomaAdvanced Unresectable Gastric AdenocarcinomaMetastatic Gastric Cancer+10 more
Memorial Sloan Kettering Cancer Center 20
Early research (Phase 1)Ended earlyNCT03854227
What this trial is testing

A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Solid Tumors
Pfizer 54
Large-scale testing (Phase 3)Looking for participantsNCT05527470
What this trial is testing

Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Wei Jiang 440
Testing effectiveness (Phase 2)Study completedNCT00022594
What this trial is testing

Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC 50
Testing effectiveness (Phase 2)Ended earlyNCT01262183
What this trial is testing

Radio-chemotherapy With or Without Panitumumab (Vectibix®) in Irresectable Squamous Cell Carcinoma or Adenocarcinoma of the Oesophagus

Who this might be right for
Irresectable Squamous Cell or Adenocarcinoma of the Oesophagus
Radboud University Medical Center 4
Testing effectiveness (Phase 2)Study completedNCT02393690
What this trial is testing

Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer

Who this might be right for
Metastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland Carcinoma+8 more
Academic and Community Cancer Research United 60
Early research (Phase 1)Looking for participantsNCT04119024
What this trial is testing

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more
Anusha Kalbasi 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05075980
What this trial is testing

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

Who this might be right for
Head and Neck CarcinomaHead and Neck Carcinoma of Unknown PrimaryHypopharyngeal Carcinoma+9 more
Mayo Clinic 174
Early research (Phase 1)Active Not RecruitingNCT05799274
What this trial is testing

Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Healthy VolunteersPancreatic Ductal AdenocarcinomaNon-small Cell Lung Cancer (NSCLC)+4 more
Radiopharm Theranostics, Ltd 9
Testing effectiveness (Phase 2)UnknownNCT03210389
What this trial is testing

A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC.

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University 60
Not applicableStudy completedNCT00628368
What this trial is testing

Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer

Who this might be right for
Colorectal CancerEsophageal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 160
Testing effectiveness (Phase 2)Study completedNCT02255097
What this trial is testing

Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 172
Not applicableUnknownNCT02119559
What this trial is testing

Circulating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell Carcinoma

Who this might be right for
Metastatic Head-and-neck Squamous-cell Carcinoma
University Hospital, Montpellier 115
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06681285
What this trial is testing

Cadonilimab Combined With Anlotinib Followed by Radiotherapy in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (CAR-RMEC)

Who this might be right for
Esophageal Carcinoma
Hebei Medical University Fourth Hospital 51
Testing effectiveness (Phase 2)UnknownNCT00005876
What this trial is testing

Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery

Who this might be right for
Esophageal CancerGastric Cancer
Astex Pharmaceuticals, Inc.
Next Page